Film doctor - Company finances
|
EUR
|
2024
From: 2024-01-30
To: 2024-12-31
|
2025
From: 2025-01-01
To: 2025-12-31
|
|---|---|---|
|
Financial data
|
||
| Sales revenue | 39,000 | 97,000 |
| Profit before tax | 2,000 | 17,000 |
| Net profit | 2,000 | 16,000 |
| Equity | 2,000 | 17,000 |
| Liabilities | 1,000 | 2,000 |
| Non-current assets | 0 | 6,000 |
| Current assets | 3,000 | 13,000 |
| Total assets | 3,000 | 19,000 |
|
Taxes paid
|
||
| STI taxes | 4,976 | 17,961 |
|
Financial indicators
|
||
| Revenue change y/y | - | +148.7% |
| ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. | 66.7% | 84.2% |
| ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. | 100.0% | 94.1% |
| Profit margin Net profit margin. Shows the overall profitability of the company. | 5.1% | 16.5% |
| EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. | 5.1% | 17.5% |
| Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. | 0.5 | 0.1 |
| Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. | - | - |
Sales revenue
See Scoris data in Google Search
Mark Scoris as a favorite source. One click, no registration.
Film doctor - Social security debts
| From | To | Debt, € |
|---|---|---|
| 2024-03-01 | 2024-03-31 | 64.50 |
Film doctor - VMI tax arrears
| From | To | Overdue, € |
|---|---|---|
| 2026-02-27 | 2026-03-21 | 0.18 |
VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.
Analysis of the company's financial position
This description was generated by artificial intelligence.
Report if inaccurate.
Film doctor, MB (code 306671938) is a Lithuanian small partnership operating in motion picture, video and television programme production activities. In 2025, the company generated EUR 97.0K in revenue, up 148.7% year on year from EUR 39.0K in 2024. Net profit increased to EUR 16.0K in 2025 from EUR 2.0K a year earlier, lifting the profit margin from 5.1% to 16.5%. The latest results show a clear improvement in operating scale and profitability over the two-year period.
The balance sheet remained compact at the end of 2025, with total assets of EUR 19.0K, equity of EUR 17.0K and liabilities of EUR 2.0K. Equity accounted for 89.5% of assets, indicating a strong capital base relative to borrowings. Key ratios for 2025 were also strong: return on equity was 94.1%, return on assets 84.2%, debt-to-equity 0.12, and asset turnover 5.11x. Overall, the company moved from a modest 2024 profit to a materially stronger 2025 result.
The balance sheet remained compact at the end of 2025, with total assets of EUR 19.0K, equity of EUR 17.0K and liabilities of EUR 2.0K. Equity accounted for 89.5% of assets, indicating a strong capital base relative to borrowings. Key ratios for 2025 were also strong: return on equity was 94.1%, return on assets 84.2%, debt-to-equity 0.12, and asset turnover 5.11x. Overall, the company moved from a modest 2024 profit to a materially stronger 2025 result.